Cyclophilin D inhibitors are a class of chemical compounds that specifically target and inhibit the activity of Cyclophilin D, a mitochondrial matrix protein that plays a crucial role in the regulation of the mitochondrial permeability transition pore (mPTP). Cyclophilin D is a peptidyl-prolyl isomerase (PPIase), an enzyme that catalyzes the cis-trans isomerization of proline residues in peptide chains, a process important for protein folding and function. Beyond its enzymatic activity, Cyclophilin D is best known for its role in modulating the mPTP, a multi-protein complex that controls the permeability of the mitochondrial membrane under conditions of stress. The opening of the mPTP can lead to loss of mitochondrial membrane potential, release of pro-apoptotic factors, and ultimately, cell death. Cyclophilin D acts as a regulatory component of this pore, influencing its sensitivity to calcium, oxidative stress, and other stimuli.
Inhibitors of Cyclophilin D are typically small molecules designed to bind to the protein and block its interaction with other components of the mPTP or to inhibit its PPIase activity. These inhibitors may act by directly binding to the active site of Cyclophilin D or by allosterically modulating its conformation, thus preventing it from exerting its regulatory effects on the mPTP. The structural design of Cyclophilin D inhibitors often involves detailed studies of the protein's three-dimensional structure, particularly the regions involved in its interaction with the mPTP and its catalytic activity. By inhibiting Cyclophilin D, researchers can explore its role in mitochondrial function, the regulation of cell death, and the broader implications of mPTP dynamics in cellular physiology. The ongoing development of Cyclophilin D inhibitors provides valuable insights into the complex interplay between mitochondrial function and cellular homeostasis, highlighting the critical role of Cyclophilin D in maintaining mitochondrial integrity and responding to cellular stress. This research contributes to a deeper understanding of how mitochondrial proteins regulate cell survival and adaptation to environmental challenges.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A might downregulate Cyclophilin D expression by interfering with mitochondrial stress pathways that would otherwise upregulate CypD. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
By binding to immunophilin FKBP, FK506 may indirectly decrease the synthesis of Cyclophilin D by altering the intracellular signaling environment. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin’s inhibition of mTOR signaling may lead to a reduction in overall protein synthesis rates, including those of Cyclophilin D. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin may decrease Cyclophilin D expression through the activation of AMPK, leading to changes in mitochondrial biogenesis and energy metabolism. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
As a glycolytic inhibitor, 2-Deoxy-D-glucose may reduce Cyclophilin D expression by imposing energy stress and reducing mitochondrial ATP production. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine’s ability to alkalize intracellular compartments may downregulate Cyclophilin D by altering the mitochondrial pH gradient. | ||||||
Decylubiquinone | 55486-00-5 | sc-358659 sc-358659A | 10 mg 50 mg | $70.00 $269.00 | 10 | |
Decylubiquinone may decrease Cyclophilin D expression through inhibition of the mitochondrial electron transport chain, reducing reactive oxygen species. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Activation of PPARγ by Rosiglitazone may lead to decreased Cyclophilin D expression as a secondary effect of altered mitochondrial function. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could downregulate Cyclophilin D expression by causing epigenetic changes that lead to a tighter chromatin structure around the CypD gene. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram’s inhibition of aldehyde dehydrogenase could create a cellular environment that is less conducive to Cyclophilin D expression. | ||||||